**PLEASE NOTE**
This event is open to Imperial staff and students, as well as colleagues at Imperial AHSC partner organisationsNHS Trusts. Imperial attendees should register here. AHSC partners should email medicine-notifications@imperial.ac.uk in advance to register and receive joining instructions.
Data-driven medicine and digital health is growing at an explosive rate and presenting both researchers and clinicians with a huge range of new challenges and opportunities. Translation for impact generally requires successful commercialisation, yet the optimal routes to commercialisation and application are varied, and often not widely understood.
Join us on Tuesday 7 October from 10:00 for our latest online mini-symposium: Translating and Commercialising Data-driven Precision Medicine and Digital Health Technology.
Chaired by Dr Mike Romanos, Faculty of Medicine Associate Dean for Enterprise, the symposium will feature contributions from experienced academics, start-ups, commercial leaders and investors. It will provide an overview of diverse technologies and routes to commercialisation, showcase real-world examples combining science with business, and offer practical advice to guide Imperial researchers to success. The symposium will conclude with an interactive panel/ audience discussion and Q&A.
The symposium will be relevant to attendees from all faculties, both medics and non-medics, with current or potential future interest in this space. Colleagues from partner NHS Trusts are also welcome.
Speakers and discussion panel include:
- Dr Mike Romanos, Associate Dean for Enterprise, Faculty of Medicine, Imperial
- Dr Barbara Domayne-Hayman, Co-Creator and Chair, KQ Labs and Entrepreneur in Residence, Francis Crick Institute
- Professor Aldo Faisal, Professor of AI and Neuroscience, Faculty of Engineering, and Director of the UKRI Centre for Doctoral Training in AI for Healthcare, Imperial
- Dr Vishal Gulati, Founder and Managing Partner, Recode Ventures
- Professor George Hanna, Chairman, Founder and CSO, Spirachek, and Head of Dept of Surgery and Cancer, Faculty of Medicine, Imperial
- Dr Maria Leiloglou, CEO, EnAcuity and Associate Research Fellow, Hamlyn Centre for Robotic Surgery, Imperial
- Dr Peter Jianrui Liu, CEO, Oxford Cancer Analytics
- Dr Rana Lonnen, Science Capital Imperial LLP
- Madhav Mahendra, Principal, Meridian Ventures
- Professor Jamil Mayet, Clinical Head of Cardiovascular Division, National Heart and Lung Institute, Imperial
- Dr Fu-Siong Ng, CEO and Founder, Cardiovolt and Clinical Associate Professor, National Heart and Lung Institute, Imperial
- Dr Mihalis Papadakis, CEO and Founder, Brainomix
The session will take place online and will be recorded for those who cannot join live. Recordings of previous events are available (to members of the University only) here.
Where: Online, via Microsoft Teams